Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

CorMedix (CRMD) Long-Term Deferred Tax (2025)

CorMedix has reported Long-Term Deferred Tax over the past 1 years, most recently at $16.3 million for Q4 2025.

Quarterly results put Long-Term Deferred Tax at $16.3 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $16.3 million (changed N/A YoY), and the annual figure for FY2025 was $16.3 million, changed.
Long-Term Deferred Tax reached $16.3 million in Q4 2025 per CRMD's latest filing, down from $52.5 million in the prior quarter.
Across five years, Long-Term Deferred Tax topped out at $52.5 million in Q3 2025 and bottomed at $16.3 million in Q4 2025.